Major Players - Ebola Vaccine Industry

Ebola Virus disease causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person in one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases internal or external bleeding.

GAVI is an international organization (global Vaccine Alliance) paid US$ 5 million to Merck & Company in 2016 for procurement of the vaccine (V 920 vaccine). Key players in the global Ebola vaccine market are Merck and Company, Janssen Pharmaceutica NV, GlaxoSmithKline, and Novavax Inc.

Prominent Companies in the Ebola Vaccine Industry:

1) Merck & C. Inc.

Merck, is a pharmaceutical institution based in America. The company’s headquarters are situated in Rahway, New Jersey. The company gets its name from Merck Group that was established in Germany in the year 1668. In the year 2022 the company ranked 71^st in the Fortune 500 companies list. And based on the revenues of 2021 it took the place as 87^th in the Forbes Global 2000.

In September 2022, Merck announced its plans of acquiring Vence, a livestock management company, incorporating it within Merck Animal Health.

2) GlaxoSmithKline GSK plc.

GSK Plc. Is a British Multinational pharmaceutical and biotechnology company founded in the year 2000. The headquarters are located in London, England, UK. GlaxoSmithKline is the tenth largest pharmaceutical company and has ranked 294^th on the 2002 Fortune Globes 500. The company was founded by Joseph Nathan. The company manufacture products for major diseases like asthma, cancer, infections and mental health.

In April 2022, the company announced its plans of acquiring Sierra Oncology Inc. for U.S$ 1.9 Billion. In May 2022, GSK announced it would acquire Affinivax and its phase II 24- Valent pneumococcal vaccine candidate for up to $3.3 Billion.

3) Janssen Pharmaceuticals

Janssen Pharmaceuticals is a pharmaceutical company. The company is wholly-owned by Johnson & Johnson. The Company offers drugs and vaccines to treat complex disorders including cancer, hepatitis, HIV, AIDS, diabetes, arthritis, dementia, and mental disorder. Janssen Pharmaceuticals serves patients and medical professionals worldwide. The company was founded by 1953, and the headquarters are located in Tumhoutseweg, Beerse, Belgium. The company was founded by Paul Janssen.

In February 2022, Janssen Pharmaceuticals announced the acquisition of Anakuria Therapeutics, a company recently formed by Navitor to advance its novel class of selective rapamycin analog mTORC1 inhibitors.

4) Novavax Inc.

Novavac Inc. is an American biotechnology company that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus, as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. The company was founded in the year 1987, and the headquarters are located in Gaithersburg, Maryland, U.S.

In February 2022, Health Canada authorized Nuvaxovid for the prevention of COVID-19 in adults 18 years of age and older.